Ibrain Indexing, Publication Fee / Time (2024)


ibrain

Aim and Scope

The Ibrain is a research journal that publishes research in the field of brain function, brain diseases, neuroscience. This journal is published by the Wiley-VCH. The ISSN of this journal is 2313-1934.

Also, please check the following important details about ibrain: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: Ibrain
Publisher: Wiley-VCH
P-ISSN: 2313-1934
E-ISSN: 2769-2795
Language: English
Country of Publisher: Germany
APC: Yes
Processing Time (Weeks): 10
Review Process: Anonymous peer review
Subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry

Indexing

The ibrain is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Publication fee

According to journal website, the publication fee of ibrain is around 2800 USD; 2060 GBP; 2428 EUR.

The ibrain has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the ibrain publishes research articles in 10 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Ibrain?

If your research is related to brain function, brain diseases, neuroscience, then visit the official website of ibrain and send your manuscript.

Tips for publishing in Ibrain:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • It is published by Wiley-VCH.
  • The journal is indexed in , DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 10 weeks.
  • The Publication fee (APC) of ibrain 2800 USD; 2060 GBP; 2428 EUR.

Sources: https://onlinelibrary.wiley.com/journal/27692795







SIMILIAR JOURNALS


ACTA ANGIOLOGICA

ISSN: 1234-950X
Publisher: VIA MEDICA

ACTA PHLEBOLOGICA

ISSN: 1593-232X
Publisher: EDIZIONI MINERVA MEDICA

AIDS RESEARCH AND TREATMENT

ISSN: 2090-1240
Publisher: HINDAWI LTD

ANGIOLOGIA

ISSN: 0003-3170
Publisher: ARAN EDICIONES, S A

ANNALS OF VASCULAR DISEASES

ISSN: 1881-641X
Publisher: ANNALS VASCULAR DISEASES EDITORIAL OFFICE

ARCHIVES OF CLINICAL INFECTIOUS DISEASES

ISSN: 2345-2641
Publisher: BRIEFLAND

ARTERIAL HYPERTENSION

ISSN: 2449-6170
Publisher: VIA MEDICA

CASE REPORTS IN INFECTIOUS DISEASES

ISSN: 2090-6625
Publisher: HINDAWI LTD

CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR

ISSN: 2666-2450
Publisher: ELSEVIER

CEREBROVASCULAR DISEASES EXTRA

ISSN: 1664-5456
Publisher: KARGER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.